Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 23540681)

1.

The metabolic syndrome and CVD outcomes for a central Australian cohort.

Luke JN, Brown A, Daniel M, O'Dea K, Best JD, Jenkins AJ, Wang Z, McDermott RA, Wang Z, Rowley KG.

Diabetes Res Clin Pract. 2013 Jun;100(3):e70-3. doi: 10.1016/j.diabres.2013.03.020. Epub 2013 Mar 26.

PMID:
23540681
2.

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J.

Eur Heart J. 2007 Apr;28(7):857-64. Epub 2007 Feb 15.

3.

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.

Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP.

Curr Med Res Opin. 2010 Mar;26(3):713-9. doi: 10.1185/03007991003590597.

PMID:
20078335
4.

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.

Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.

PMID:
16854482
5.

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.

6.

Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM.

J Intern Med. 2013 Jun;273(6):595-601. doi: 10.1111/joim.12036. Epub 2013 Feb 18.

PMID:
23331522
7.

Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.

Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):235-41. doi: 10.1097/HJR.0b013e32832955fc.

PMID:
19238082
8.

Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes.

Sidorenkov O, Nilssen O, Grjibovski AM.

BMC Public Health. 2010 Sep 29;10:582. doi: 10.1186/1471-2458-10-582.

9.

Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.

He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB.

J Am Coll Cardiol. 2006 Apr 18;47(8):1588-94. Epub 2006 Mar 29.

10.

The metabolic syndrome in Australia: prevalence using four definitions.

Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE.

Diabetes Res Clin Pract. 2007 Sep;77(3):471-8. Epub 2007 Mar 12.

PMID:
17350710
11.

Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.

PMID:
17259468
12.
13.

Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study.

Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky VL, Grjibovski AM.

BMC Public Health. 2010 Jan 19;10:23. doi: 10.1186/1471-2458-10-23.

14.

Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.

Maksimovic MZ, Vlajinac HD, Radak DJ, Marinkovic JM, Jorga JB.

BMC Cardiovasc Disord. 2012 Jan 31;12:2. doi: 10.1186/1471-2261-12-2.

15.

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study.

Circulation. 2004 Sep 7;110(10):1251-7. Epub 2004 Aug 23.

16.

Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.

Hirota AH, Rodrigues CJ, Borges RL, Ribeiro AB, Zanella MT, Batista MC.

J Clin Hypertens (Greenwich). 2010 Aug;12(8):588-96. doi: 10.1111/j.1751-7176.2010.00313.x.

PMID:
20695935
17.

Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.

Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H.

Hypertens Res. 2008 Nov;31(11):2027-35. doi: 10.1291/hypres.31.2027.

PMID:
19098374
19.

Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.

Li WJ, Xue H, Sun K, Song XD, Wang YB, Zhen YS, Han YF, Hui RT.

Chin Med J (Engl). 2008 Aug 20;121(16):1532-6.

PMID:
18985935
20.

Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.

Zhang ML, Hou XH, Zhu YX, Lu JX, Peng LP, Gu HL, Jia WP.

Biomed Environ Sci. 2012 Feb;25(1):38-45. doi: 10.3967/0895-3988.2012.01.006.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk